CRISPR Therapeutics AG ( CRSP) - Key Metrics
CRSP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.11 | -$0.94 | -$1.99 | -$2.01 |
| 2026Q1 | $0.02 | -$1.28 | -$1.13 | -$1.14 |
| 2025Q4 | $0.01 | -$1.45 | -$1.03 | -$1.03 |
| 2025Q3 | $0.01 | -$1.17 | -$0.93 | -$0.93 |
| 2025Q2 | $0.01 | -$2.40 | -$1.31 | -$1.31 |
CRSP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -14.51 |
| 2026Q1 | 0% | -9.29 |
| 2025Q4 | 0% | -9.57 |
| 2025Q3 | 0% | -13.85 |
| 2025Q2 | 0% | -5.07 |
CRSP
Price: $49.25
52 week price:
Earnings Per Share: -4.71 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 1.2 million
Ebitda: -23.2 millionMarket Capitalization: 5.3 billion